Fig. 1From: Dosimetric benefits of adaptive radiation therapy for patients with stage III non-small cell lung cancerExemplary dose distributions of a representative patient. Shown are dose distributions (a) of the original treatment plan, (b) of the last treatment fraction without adaptive radiotherapy (ART), (c) of an isoeffective ART, and (d) of an isotoxic ART treatment planBack to article page